Pre-conference dinner with key European stakeholders

PROHEALTH is delighted to have the chance to present its final results in front of high profile European stakeholders, including representatives of the European Parliament and its Science and Technology Options Assessment (STOA) panel and its Committee on Agriculture and Rural Development (AGRI), as well as of the European Commission specialized agencies, researchers and investors. The framework for this exchange will be formed by a dinner event organised at the premises of the European Parliament in Brussels on Monday, 26 November. At this event, PROHEALTH coordinator Prof. Ilias Kyriazakis (Newcastle University) and Dr. Theo Kanellos (PROHEALTH member Zoetis, representing the industry Stakeholders of the Consortium) will speak about the increased understanding of the multi-factorial dimension of animal pathologies linked to the intensification of production in EU and how this can be used to improve pig and poultry health and welfare. Some emphasis will be given on the novel diagnostic and digital opportunities, some of which have been developed by PROHEALTH, in addressing these issues. They will also present the main conclusions from the project and how they can contribute to address the main challenges faced by the livestock farming sector across the EU. Participants will hear and get the chance to debate what is at stake regarding the animal health and welfare in Europe, the circular economy perspectives and the innovation challenges in the European and the global market. 

While the event in Brussels is only for invited participants, including the Work Package Leaders of PROHEALTH, the following two days the PROHEALTH members will present their results in detail in the Industry Workshops and the Scientific Symposium, open for everyone interested, in Ghent on 27-28 November (see next article). The main conclusions and recommendations are also compiled in compact form in the Policy Briefs and Best Practice guidelines. The landscape of farming pigs and poultry in the EU is changing very rapidly, whilst facing new challenges, such as African Swine Fever and the need to find new ways of tackling production diseases in the face of the threat from antimicrobial resistance. The hope is that PROHEALTH has contributed to offering solutions in this respect.

Figure 1. European Parliament